Home » Topics » BioWorld Science

BioWorld Science
RSS

Accent Therapeutics launches to create innovative therapeutics in area of epitranscriptomics

May 22, 2018

Docetaxel nanoemulsion with theranostic properties selectively targets ovarian cancer cells

May 22, 2018

Bayer patents Wnt signaling and/or tankyrase-1/2 inhibitors

May 22, 2018

Daewoong Pharmaceutical presents TNF-alpha production inhibitors

May 18, 2018

Damian Pharma discloses CYP11B2 inhibitors

May 18, 2018

CRISPR Therapeutics designs new method for generating BCMA-targeted CAR-T cells

May 18, 2018

Beijing Konruns Pharmaceutical divulges UFO and VEGFR-2 inhibitors

May 18, 2018

Qingdao Marine Biomedical Research Institute patents ROS-production inhibitors

May 18, 2018

IDAC Theranostics and Keio University present apoptosis inducers

May 18, 2018

MET inhibitor OMO-1 shows promising preclinical antitumoral activity

May 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...